Nuvalent Historical Financial Ratios
| NUVL Stock | USD 77.93 3.02 3.73% |
Nuvalent is lately reporting on over 81 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Nuvalent financial condition quickly.
Nuvalent |
About Nuvalent Financial Ratios Analysis
NuvalentFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Nuvalent investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Nuvalent financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Nuvalent history.
Nuvalent Financial Ratios Chart
Add Fundamental
Income Quality
An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.Current Ratio
A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.Most ratios from Nuvalent's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Nuvalent current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.At this time, Nuvalent's Net Debt To EBITDA is quite stable compared to the past year. Tangible Book Value Per Share is expected to rise to 11.37 this year, although the value of Operating Cash Flow Per Share is projected to rise to (1.87).
Nuvalent fundamentals Correlations
Click cells to compare fundamentals
Nuvalent Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nuvalent fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | (28.9) | 3.23 | 3.19 | 6.12 | 5.5 | 5.78 | |
| Book Value Per Share | (0.65) | 5.9 | 9.32 | 12.03 | 10.83 | 11.37 | |
| Free Cash Flow Yield | (0.0165) | (0.0435) | (0.0439) | (0.0233) | (0.0268) | (0.0281) | |
| Operating Cash Flow Per Share | (0.31) | (0.83) | (1.31) | (1.71) | (1.97) | (1.87) | |
| Pb Ratio | (28.9) | 3.23 | 3.19 | 6.12 | 5.5 | 5.78 | |
| Free Cash Flow Per Share | (0.31) | (0.83) | (1.31) | (1.71) | (1.97) | (1.87) | |
| Roic | (2.69) | (0.16) | (0.17) | (0.21) | (0.25) | (0.23) | |
| Net Income Per Share | (0.3) | (0.96) | (1.48) | (2.17) | (2.49) | (2.37) | |
| Cash Per Share | 0.21 | 5.97 | 9.51 | 12.36 | 11.13 | 11.68 | |
| Pocfratio | (60.56) | (22.99) | (22.77) | (42.96) | (38.66) | (40.6) | |
| Pfcf Ratio | (60.56) | (22.99) | (22.77) | (42.96) | (38.66) | (40.6) | |
| Ev To Operating Cash Flow | (60.02) | (21.28) | (19.04) | (39.6) | (35.64) | (37.42) | |
| Pe Ratio | (62.2) | (19.85) | (20.17) | (33.95) | (30.55) | (32.08) | |
| Ev To Free Cash Flow | (60.02) | (21.28) | (19.04) | (39.6) | (35.64) | (37.42) | |
| Earnings Yield | (0.0161) | (0.0504) | (0.0496) | (0.0295) | (0.0339) | (0.0356) | |
| Net Debt To E B I T D A | (3.45) | 1.5 | 2.81 | 2.66 | 2.39 | 2.51 | |
| Current Ratio | 2.43 | 33.07 | 24.54 | 22.83 | 20.55 | 13.38 | |
| Tangible Book Value Per Share | (0.65) | 5.9 | 9.32 | 12.03 | 10.83 | 11.37 | |
| Graham Number | 2.1 | 11.29 | 17.6 | 24.23 | 21.8 | 22.89 | |
| Shareholders Equity Per Share | (0.65) | 5.9 | 9.32 | 12.03 | 10.83 | 11.37 | |
| Graham Net Net | (0.66) | 5.78 | 9.11 | 11.82 | 10.64 | 11.17 | |
| Enterprise Value Over E B I T D A | 381.96 | (18.58) | (14.37) | (31.29) | (28.16) | (29.57) | |
| Price Earnings Ratio | (62.2) | (19.85) | (20.17) | (33.95) | (30.55) | (32.08) | |
| Price Book Value Ratio | (28.9) | 3.23 | 3.19 | 6.12 | 5.5 | 5.78 | |
| Price To Operating Cash Flows Ratio | (60.56) | (22.99) | (22.77) | (42.96) | (38.66) | (40.6) | |
| Price To Free Cash Flows Ratio | (60.56) | (22.99) | (22.77) | (42.96) | (38.66) | (40.6) | |
| Ebt Per Ebit | 0.86 | 1.01 | 0.95 | 0.84 | 0.97 | 1.06 | |
| Company Equity Multiplier | (0.34) | 1.03 | 1.04 | 1.05 | 0.94 | 0.99 | |
| Return On Capital Employed | (2.7) | (0.16) | (0.19) | (0.21) | (0.25) | (0.23) | |
| Quick Ratio | 2.43 | 33.07 | 24.54 | 22.83 | 20.55 | 13.38 | |
| Cash Ratio | 2.36 | 7.8 | 12.41 | 10.54 | 9.49 | 5.41 | |
| Price To Book Ratio | (28.9) | 3.23 | 3.19 | 6.12 | 5.5 | 5.78 | |
| Price Cash Flow Ratio | (60.56) | (22.99) | (22.77) | (42.96) | (38.66) | (40.6) | |
| Enterprise Value Multiple | 381.96 | (18.58) | (14.37) | (31.29) | (28.16) | (29.57) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.